SLS

SELLAS Life Sciences Group (SLS)

About SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Details

Daily high

$12.18

Daily low

$11.59

Price at open

52 Week High

$15.88

52 Week Low

$1.39

Market cap

2.2B

Dividend yield

0.00%

Volume

2,566

Avg. volume

6.7M

P/E ratio

-51.93

SELLAS Life Sciences Group News